These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32814254)

  • 21. Why TAPBPR? Implications of an additional player in MHC class I peptide presentation.
    Hafstrand I; Aflalo A; Boyle LH
    Curr Opin Immunol; 2021 Jun; 70():90-94. PubMed ID: 34052734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Get into the groove! The influence of TAPBPR on cargo selection.
    Satti R; Morley JL; Boyle LH
    Curr Opin Immunol; 2023 Aug; 83():102346. PubMed ID: 37295041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR.
    Ilca FT; Drexhage LZ; Brewin G; Peacock S; Boyle LH
    Cell Rep; 2019 Nov; 29(6):1621-1632.e3. PubMed ID: 31693900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chaperones and Catalysts: How Antigen Presentation Pathways Cope With Biological Necessity.
    Margulies DH; Taylor DK; Jiang J; Boyd LF; Ahmad J; Mage MG; Natarajan K
    Front Immunol; 2022; 13():859782. PubMed ID: 35464465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of peptide loading into major histocompatibility complex class I molecules chaperoned by TAPBPR.
    Xu H; Song K; Da LT
    Phys Chem Chem Phys; 2022 May; 24(20):12397-12409. PubMed ID: 35575131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection.
    McShan AC; Devlin CA; Overall SA; Park J; Toor JS; Moschidi D; Flores-Solis D; Choi H; Tripathi S; Procko E; Sgourakis NG
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25602-25613. PubMed ID: 31796585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editing.
    van Hateren A; Elliott T
    Curr Opin Immunol; 2021 Jun; 70():138-143. PubMed ID: 34265495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chaperone function in antigen presentation by MHC class I molecules-tapasin in the PLC and TAPBPR beyond.
    Margulies DH; Jiang J; Ahmad J; Boyd LF; Natarajan K
    Front Immunol; 2023; 14():1179846. PubMed ID: 37398669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the TAPBPR-MHC I complex defines the mechanism of peptide loading and editing.
    Thomas C; Tampé R
    Science; 2017 Nov; 358(6366):1060-1064. PubMed ID: 29025996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules.
    Lan BH; Becker M; Freund C
    J Biol Chem; 2023 Apr; 299(4):102987. PubMed ID: 36758805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC I chaperone complexes shaping immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2019 Jun; 58():9-15. PubMed ID: 30771631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.
    Natarajan K; Jiang J; Margulies DH
    Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):164-173. PubMed ID: 31084439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes.
    Sun Y; Papadaki GF; Devlin CA; Danon JN; Young MC; Winters TJ; Burslem GM; Procko E; Sgourakis NG
    Sci Adv; 2023 Feb; 9(8):eade7151. PubMed ID: 36827371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.
    McShan AC; Devlin CA; Papadaki GF; Sun Y; Green AI; Morozov GI; Burslem GM; Procko E; Sgourakis NG
    Nat Chem Biol; 2022 Aug; 18(8):859-868. PubMed ID: 35725941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAPBPR isoforms exhibit altered association with MHC class I.
    Porter KM; Hermann C; Traherne JA; Boyle LH
    Immunology; 2014 Jun; 142(2):289-99. PubMed ID: 24444341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells.
    Schoenhals GJ; Krishna RM; Grandea AG; Spies T; Peterson PA; Yang Y; Früh K
    EMBO J; 1999 Feb; 18(3):743-53. PubMed ID: 9927434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of the human MHC-I peptide-loading complex.
    Blees A; Januliene D; Hofmann T; Koller N; Schmidt C; Trowitzsch S; Moeller A; Tampé R
    Nature; 2017 Nov; 551(7681):525-528. PubMed ID: 29107940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC I assembly and peptide editing - chaperones, clients, and molecular plasticity in immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2021 Jun; 70():48-56. PubMed ID: 33689959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stoichiometric tapasin interactions in the catalysis of major histocompatibility complex class I molecule assembly.
    Bangia N; Cresswell P
    Immunology; 2005 Mar; 114(3):346-53. PubMed ID: 15720436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.